Targeting the Urotensin II/UT G Protein-Coupled Receptor to Counteract Angiogenesis and Mesenchymal Hypoxia/Necrosis in Glioblastoma.

Le Joncour, Vadim; Guichet, Pierre-Olivier; Dembélé, Kleouforo-Paul; Mutel, Alexandre; Campisi, Daniele; Perzo, Nicolas; Desrues, Laurence; Modzelewski, Romain; Couraud, Pierre-Olivier; Honnorat, Jérôme; Ferracci, François-Xavier; Marguet, Florent; Laquerrière, Annie; Vera, Pierre; Bohn, Pierre; Langlois, Olivier; Morin, Fabrice; Gandolfo, Pierrick; Castel, Hélène

Le Joncour, Vadim; Guichet, Pierre-Olivier; Dembélé, Kleouforo-Paul; Mutel, Alexandre; Campisi, Daniele; Perzo, Nicolas; Desrues, Laurence; Modzelewski, Romain; Couraud, Pierre-Olivier; Honnorat, Jérôme; Ferracci, François-Xavier; Marguet, Florent; Laquerrière, Annie; Vera, Pierre; Bohn, Pierre; Langlois, Olivier; Morin, Fabrice; Gandolfo, Pierrick; Castel, Hélène.

Afiliação

Le Joncour V; UNIROUEN, INSERM U1239, DC2N, Institute for Research and Innovation in Biomedicine (IRIB), Normandie Rouen Université, Rouen, France.
Guichet PO; UNIROUEN, INSERM U1239, DC2N, Institute for Research and Innovation in Biomedicine (IRIB), Normandie Rouen Université, Rouen, France.
Dembélé KP; UNIROUEN, INSERM U1239, DC2N, Institute for Research and Innovation in Biomedicine (IRIB), Normandie Rouen Université, Rouen, France.
Mutel A; UNIROUEN, INSERM U1239, DC2N, Institute for Research and Innovation in Biomedicine (IRIB), Normandie Rouen Université, Rouen, France.
Campisi D; UNIROUEN, INSERM U1239, DC2N, Institute for Research and Innovation in Biomedicine (IRIB), Normandie Rouen Université, Rouen, France.
Perzo N; UNIROUEN, INSERM U1239, DC2N, Institute for Research and Innovation in Biomedicine (IRIB), Normandie Rouen Université, Rouen, France.
Desrues L; UNIROUEN, INSERM U1239, DC2N, Institute for Research and Innovation in Biomedicine (IRIB), Normandie Rouen Université, Rouen, France.
Modzelewski R; EA 4108, Laboratoire d'Informatique, de Traitement de l'Information et des Systèmes (LITIS), University of Rouen, Mont-Saint-Aignan, France.
Couraud PO; Université de Paris, Institut Cochin, Inserm U1016, CNRS UMR 8104, Paris, France.
Honnorat J; Neuro-Oncology Department, Hospices Civils de Lyon, Hôpital Neurologique, Bron, France.
Ferracci FX; Institute NeuroMyoGéne, INSERM U1217/CNRS UMR 5310, Lyon, France.
Marguet F; University Claude Bernard Lyon 1, Université de Lyon, Lyon, France.
Laquerrière A; UNIROUEN, INSERM U1239, DC2N, Institute for Research and Innovation in Biomedicine (IRIB), Normandie Rouen Université, Rouen, France.
Vera P; Neurosurgery Service, Rouen CHU Hospital, Rouen, France.
Bohn P; Anathomocytopathology Service, Rouen CHU Hospital, Rouen, France.
Langlois O; Anathomocytopathology Service, Rouen CHU Hospital, Rouen, France.
Morin F; EA 4108, Laboratoire d'Informatique, de Traitement de l'Information et des Systèmes (LITIS), University of Rouen, Mont-Saint-Aignan, France.
Gandolfo P; EA 4108, Laboratoire d'Informatique, de Traitement de l'Information et des Systèmes (LITIS), University of Rouen, Mont-Saint-Aignan, France.
Castel H; UNIROUEN, INSERM U1239, DC2N, Institute for Research and Innovation in Biomedicine (IRIB), Normandie Rouen Université, Rouen, France.